menu search

PLLWF / Polarean Imaging looking to gain commercial traction for its XENOVIEW

Polarean Imaging looking to gain commercial traction for its XENOVIEW
Polarean Imaging PLC (AIM:POLX, OTC:PLLWF) is looking to gain "commercial traction" for its medical imaging product, XENOVIEW, the first and only FDA-approved hyperpolarised MRI contrast agent, said chief executive Richard Hullihen in an investor update. The company, which finished 2022 with $16 million in cash, plans to maximise commercial sales of XENOVIEW and pursue collaborations with pharmaceutical and MRI companies and other strategic partners to fund future applications of the company's technology. Read More
Posted: Feb 13 2023, 02:57
Author Name: Proactive Investors
Views: 110764

PLLWF News  

Polarean Imaging partners up to enhance potential of Xenon 129 MRI technology

By Proactive Investors
September 8, 2023

Polarean Imaging partners up to enhance potential of Xenon 129 MRI technology

Polarean Imaging PLC (AIM:POLX, OTC:PLLWF) (AIM: POLX), a specialist in advanced magnetic resonance imaging (MRI) for the lungs, has announced a strat more_horizontal

Polarean Imaging new CEO sets out new sales initiatives, extends cash runway

By Proactive Investors
September 7, 2023

Polarean Imaging new CEO sets out new sales initiatives, extends cash runway

New Polarean Imaging PLC chief executive Christopher von Jako said he has identified five growth initiatives that also extend the group's cash runway more_horizontal

Plarean Imaging says Medicare code in line with expectations

By Proactive Investors
September 5, 2023

Plarean Imaging says Medicare code in line with expectations

Polarean Imaging said it has been issued a US reimbursement code for its XENOVIEW lung imaging technology that corresponds to a payment range of betw more_horizontal

Polarean Imaging up 8% as US grant reimbursement code

By Proactive Investors
August 29, 2023

Polarean Imaging up 8% as US grant reimbursement code

Polarean Imaging rose 8% as the US granted it a crucial reimbursement code, meaning its technology can be used in private and public healthcare progra more_horizontal

Polarean Imaging MRI technology granted billing code for healthcare providers

By Proactive Investors
August 29, 2023

Polarean Imaging MRI technology granted billing code for healthcare providers

Polarean Imaging PLC (AIM:POLX, OTC:PLLWF)'s magnetic resource imaging (MRI) contrasting agent has been granted a reimbursement code in the United Sta more_horizontal

Polarean hits another key milestone with University of Missouri upgrade

By Proactive Investors
July 31, 2023

Polarean hits another key milestone with University of Missouri upgrade

Polarean Imaging PLC (AIM:POLX, OTC:PLLWF), a leader in advanced lung MRI scanning, has upgraded the University of Missouri Health Care (MU Health Car more_horizontal

Polarean Imaging appoints new CEO as Hullihen prepares to retire

By Proactive Investors
June 21, 2023

Polarean Imaging appoints new CEO as Hullihen prepares to retire

Polarean Imaging PLC (AIM:POLX, OTC:PLLWF) has appointed Christopher von Jako as its new chief executive. Effective immediately, von Jako takes over more_horizontal

Polarean Imaging and electrical giant Phillps in lung imaging collaboration

By Proactive Investors
June 2, 2023

Polarean Imaging and electrical giant Phillps in lung imaging collaboration

Polarean Imaging said it has entered into a collaboration with Dutch electrical giant Philips to advance the field of hyperpolarised Xenon MRI. Philip more_horizontal


Search within

Pages Search Results: